Cooper Cos Stock News

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.

The Cooper Companies, Inc. (NASDAQ:COO ) Q4 2024 Earnings Conference Call December 5, 2024 5:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations & Risk Management Albert White - President & Chief Executive Officer Brian Andrews - Chief Financial Officer & Treasurer Conference Call Participants Craig Bijou - Bank of America Larry Biegelsen - Wells Fargo Jeffrey Johnson ...

SAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024.

The Cooper Companies have significantly grown its fertility segment with acquisitions in recent years and now boasts a robust portfolio of over 600 products supporting various fertility treatments with a global footprint. Fertility rates are declining globally, with countries implementing policies to boost birth rates, making fertility services increasingly essential. The scale of the issue is ...

SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- #O2Investment--O2 Investment Partners is excited to announce the official branding of its pool services platform, Azureon, established in June 2024.

I reiterate a ‘Buy' rating for Cooper with a fair value of $120 per share due to their strong market share gains and strategic acquisitions. CooperVision's revenue grew 10% organically, driven by their focus on Torics, Multifocal, and daily disposable contact lenses, outpacing the market's 7% growth. Recent acquisitions of obp Surgica and ZyMōt Fertility align with Cooper's M&A strategy, enhanc...

Leading global medical device company recognized for culture that drives innovation for customers and patients Leading global medical device company recognized for culture that drives innovation for customers and patients